focus -WSS

focus

author：knowledge 2025-10-01 17:21:02 - browse：43458

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Roche subsidiary Foundation Medicine opens new headquarters

hotspot

explore

WSS

Primary care physicians play key roles in Alzheimer's management

How to convince healthy people to buy insurance

States should stop sabotaging methadone treatment reform

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Bill would allow buprenorphine prescription for addiction via telehealth

The health care issue Democrats can’t solve: hospital reform

focus

focus

knowledge

Psychedelics group wrestles with new pharma identity

Readout LOUD podcast: mifepristone case, GLP

Medicare proposal to cover medical devices draws a mixed reaction

Infant mortality in U.S. rose last year for first time in decades: CDC

The cancer drug shortage isn’t new — and neither are the solutions

There's no autism epidemic. It's an autism diagnosis epidemic

Supreme Court strikes down use of affirmative action

Kidney transplant patients stopped immunosuppressants in trial

ChatGPT in medicine: STAT answers readers' burning questions

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Wikipedia

States should stop sabotaging methadone treatment reform

Primary care physicians play key roles in Alzheimer's management

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Explaining an after

The Readout: Lenmeldy, GLP

Eliminate the waiting period for sterilization covered by Medicaid

hotspot

hotspot

explore

focus